Evidence map›Paper›PMID 40792129›Full record

ArticleTranslational cancer research2025

Clinical pathological characteristics correlation of

Juan Du, Siying Liu, Lei Miao, Huijun Yang, Jiayao Li, Fei Wang, Xuzhi Wang, Ningning Shen, Zhiqing Yang, Lifang Gao and 2 more

Abstract read
In one paragraph

Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Juan Du *Department of Pathology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Siying Liu *The Second Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Lei MiaoThe Basic School of Shanxi Medical University, Taiyuan, China.
Huijun YangThe Second Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Jiayao LiThe Second Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Fei WangThe Second Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Xuzhi WangThe Second Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Ningning ShenDepartment of Pathology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Zhiqing YangDepartment of Pathology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Lifang GaoDepartment of Pathology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Wenxia MaDepartment of Pathology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Chen WangDepartment of Pathology, The Second Hospital of Shanxi Medical University, Taiyuan, China.ORCID https://orcid.org/0000-0002-4919-9677

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Giant cell tumor of bone (GCTB) has been a common primary bone tumor with potential malignancy and local aggressiveness. Methods: A total of 96 cases of GCTB samples diagnosed by two registered pathologists in the Second Hospital of Shanxi Medical University from January 2019 to December 2023 were collected. The clinical and pathological features of the samples were evaluated by pathological hematoxylin and eosin (HE) staining combined with immunohistochemistry (IHC) experiments. Results: Among the 96 GCTB cases, Conclusions: Multiple clinicopathological features of GCTB including Campanacci grading system, soft tissue invasion, and

Indexed as

Giant cell tumor of bone (GCTB)H3F3A geneneoplasm recurrencepathological featuresprognosis

Identifiers

PMID40792129
PMCPMC12335698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.